Small Volume Parenteral Market Report 2026

Small Volume Parenteral Market Overview

• Small Volume Parenteral market size has reached to $191.36 billion in 2025 • Expected to grow to $275.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Rising Numbers Of Surgeries Drives Growth Of Small-Volume Parenteral Market • Market Trend: Prefilled, Ready-To-Use Injectable Formulations Aim To Enhance Patient Safety And Dosing Accuracy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Small Volume Parenteral Market?

Small volume parenteral (SVP) refers to a category of sterile drug products that are intended for parenteral administration (bypassing the gastrointestinal tract) and are typically provided in volumes of 100 milliliters (mL) or less. These products are used for various medical purposes, including delivering medications, vaccines, or biological treatments directly into the body via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes. The main types of small volume parenteral are ampules, vials, and prefilled syringes. Ampules are small, sealed vials used to contain and preserve a sample, usually a liquid medication, which is opened by snapping off the neck. These come in single doses and multiple doses and are used to treat various indications such as pain management, cancer care, malnourishment, gastrointestinal disorder or diarrhea, diabetes, and others. These have found applications in local anesthetics, vaccines, and others and are used by several end users, such as hospitals, clinics, ambulatory surgical centers, and others.

What Is The Small Volume Parenteral Market Growth Forecast?

The small volume parenteral market size is expected to see strong growth in the next few years. It will grow to $275.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing demand for biologics and vaccines, rising adoption of self-injectable therapies, expansion of aseptic manufacturing capacity, growing focus on advanced drug delivery systems, increasing investments in sterile packaging technologies. Major trends in the forecast period include increasing adoption of prefilled syringe formats, rising demand for sterile injectable drugs, growing use of single-dose parenterals, expansion of vaccine and biologic administration, enhanced focus on drug safety and stability.

Global Small Volume Parenteral Market Segmentation

1) By Type: Ampules, Vials, Prefilled Syringes 2) By Dose Type: Single Dose, Multiple Dose 3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorders, Diabetes, Other Indications 4) By Application: Local Anesthetics, Vaccines, Other Applications 5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users Subsegments: 1) By Ampules: Glass Ampules, Plastic Ampules 2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials 3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes

What Is The Driver Of The Small Volume Parenteral Market?

The increasing number of surgeries is expected to propel the growth of the small-volume parenteral market going forward. Surgery is a medical specialty that involves using operative techniques to investigate or treat a pathological condition such as disease or injury, improve bodily function or appearance, or repair unwanted ruptured areas. The rate of surgeries is rising due to advancements in medical technology and an aging population, increasing the demand for surgical interventions. Small-volume parenteral solutions are used in surgeries to precisely administer medications, electrolytes, and nutrients directly into the bloodstream. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing number of surgeries is driving the growth of the small-volume parenteral market.

Key Players In The Global Small Volume Parenteral Market

Major companies operating in the small volume parenteral market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Viatris Inc, Intas Pharmaceuticals Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Zydus Cadila, Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

Global Small Volume Parenteral Market Trends and Insights

Major companies operating in the small-volume parenteral market are focusing on developing innovative solutions, such as prefilled, ready-to-use injectable formulations, to enhance dosing accuracy, reduce contamination risk, and improve patient safety. Prefilled, ready-to-use injectable formulations are medications that come already measured in a sterile syringe or vial, allowing healthcare providers to administer the drug directly without additional preparation. For instance, in June 2025, Gland Pharma Limited, an India-based generic injectable-focused pharmaceutical company, received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate Injection 2.5 mg/mL. The injection is indicated for rapidly increasing blood pressure in adults experiencing septic or distributive shock when conventional treatments are insufficient. It acts by binding to vascular smooth muscle receptors, inducing vasoconstriction, and promoting aldosterone release, with a rapid onset that typically achieves target blood pressure within five minutes. Administered intravenously, the dosage is carefully titrated to maintain the desired blood pressure, providing critical support for patients who remain hypotensive despite fluid resuscitation and vasopressor therapy.

What Are Latest Mergers And Acquisitions In The Small Volume Parenteral Market?

In February 2024, Eris Lifesciences Ltd., an India-based pharmaceutical company, acquired a 51% stake in Swiss Parenteral for $76.52 million. This acquisition expands Eris's presence in the sterile injectables market and complements its focus on emerging markets. Swiss Parenteral is an India-based pharmaceutical company that manufactures small-volume liquid parenteral as part of its pharmaceutical formulations.

Regional Outlook

North America was the largest region in the small volume parenteral market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Small Volume Parenteral Market?

The small volume parenteral market consists of sales of insulin, epinephrine, morphine, heparin, and vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.